All Follicular Thyroid Cancer Articles

You’ve just been diagnosed with thyroid cancer. Now what? Our helpful guide to choosing a surgeon, what to expect in the hospital and during recovery with advice from Catherine Sinclair, MD, FRACS, director of the division of head and neck surgery at Mt. Sinai West and an attending surgeon at Mt. Sinai Cancer Centers of New York.

New research shows that excess weight may be slowing down the thyroid, instead of a slow thyroid making it easy to pack on the pounds, says Cari Kitahara, PhD, MHS, an epidemiologist at the National Cancer Institute who presented her findings on obesity, thyroid function and weight at the 86th annual meeting of the American Thyroid Association in Denver Sept. 24.

Many experts are now saying that not everyone with thyroid cancer may need immediate treatment—or any treatment at all—according to a Mayo Clinic expert speaking at the opening session of the American Thyroid Associaiton's 86th annual meeting in Denver.

After initial treatment for thyroid cancer, it is essential that you periodically follow-up with your doctor. Your doctor may recommend you receive a physical examination and full evaluation every 6 months or yearly.

Radioactive iodine therapy (RAI), also known as radioiodine remnant ablation (RRA), is a treatment some patients with papillary or follicular thyroid cancer may receive after thyroidectomy. RAI or RRA is administered to destroy remaining (or remnant) thyroid cells after surgery.

Thyroid cancer is a cancer that starts in the thyroid gland, a small butterfly-shaped gland located in the middle of the neck below the Adam’s apple. Thyroid cancer is relatively common, with 62,980 new cases reported in the United States in 2014.

Thyroid cancer that has spread throughout the body can dramatically worsen a patient's prognosis, but new research suggests that in the case of bone metastases, radioactive iodine (I-131) therapy may be a reliable treatment.

In infrequent cases, clumps of thyroid cells can develop from birth in bodily sites other than the gland itself. Called ectopic thyroid, this tissue is subject to cancer just like any other organ, leading in rare instances to ectopic thyroid cancer (ETC).

Research conducted by a team of Greek and American endocrinologists has revealed that too little of the metabolic protein adiponectin in the blood may increase the likelihood of thyroid cancer, while higher levels may entail a lower-than-average risk of the disease.

Among people with phosphatase and tensin homolog (PTEN) hamartoma tumor syndrome (PHTS), the lifetime risk of developing thyroid cancer is much higher - even in childhood, according to a recent set of case studies.

Having a large thyroid nodule does not necessarily indicate the presence of thyroid cancer, but physicians often recommend the use of an ultrasound-guided fine-needle aspiration biopsy (FNAB) in order to determine whether such a growth is benign or malignant.

Policy and Contact

This information is not designed to replace a physician's independent judgment about the appropriateness or
risks of a procedure for a given patient. Always consult your doctor about your medical conditions. Vertical
Health & EndocrineWeb do not provide medical advice, diagnosis or treatment. Use of this website is
conditional upon your acceptance of our user agreement.